Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v6-EN
Language French English
Date Updated 2023-05-30 2022-03-04
Drug Identification Number 02514796 02514796
Brand name REDDY-DASATINIB REDDY-DASATINIB
Common or Proper name Dasatinib Tablets Dasatinib Tablets
Company Name DR REDDY'S LABORATORIES LTD DR REDDY'S LABORATORIES LTD
Ingredients DASATINIB DASATINIB
Strength(s) 140MG 140MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size HDPE bottles containing 30 tablets and blister packs of 30 tablets HDPE bottles containing 30 tablets and blister packs of 30 tablets
ATC code L01EA L01EA
ATC description
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2022-01-06 2022-01-06
Actual start date 2022-01-06 2022-01-06
Estimated end date 2024-12-31 2022-05-31
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Please contact customer service 1-855-550-5528 (Monday to Friday from: 9:00 am to 5:00 pm ET). Please contact customer service 1-855-550-5528 (Monday to Friday from: 9:00 am to 5:00 pm ET).
Health Canada comments